Abstract
Aspirin, one of the most commonly used anti-inflammatory drugs, has been recently reported to display multiple effects in the central nervous system (CNS), including neuroprotection and upregulation of ciliary neurotrophic factor (CNTF) expression in astrocytes. Although it was most recently reported that aspirin could promote the proliferation and differentiation of oligodendrocyte precursor cells (OPCs) after white matter lesion, the underlying mechanisms remain unclear. To dissect the effects of aspirin on oligodendroglial development and explore possible mechanisms, we here demonstrated the following: (i) in vitro treatment of aspirin on OPC cultures significantly increased the number of differentiated oligodendrocytes (OLs) but had no effect on the number of proliferative OPCs, indicating that aspirin can promote OPC differentiation but not proliferation; (ii) in vivo treatment of aspirin on neonatal (P3) rats for 4 days led to a nearly twofold increase in the expression of myelin basic protein (MBP), devoid of change in OPC proliferaion, in the corpus callosum (CC); (iii) finally, aspirin treatment increased the phosphorylation level of β-catenin and counteracted Wnt signaling pathway synergist QS11-induced suppression on OPC differentiation. Together, our data show that aspirin can directly target oligodendroglial lineage cells and promote their differentiation through inhibition of Wnt/β-catenin signaling pathway. These findings suggest that aspirin may be a novel candidate for the treatment of demyelinating diseases.
Similar content being viewed by others
References
Emery B (2010) Regulation of oligodendrocyte differentiation and myelination. Science 330(6005):779–782. doi:10.1126/science.1190927
Franklin RJ, Ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9(11):839–855. doi:10.1038/nrn2480
Balabanov R, Popko B (2005) Myelin repair: developmental myelination redux? Nat Neurosci 8(3):262–264
Sokolov BP (2007) Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies? Int J Neuropsychopharmacol 10(4):547–555
Konrad A, Winterer G (2008) Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophr Bull 34(1):72–92
Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V (2006) Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol Dis 21(3):531–540
Dubois-Dalcq M, Ffrench-Constant C, Franklin RJ (2005) Enhancing central nervous system remyelination in multiple sclerosis. Neuron 48(1):9–12. doi:10.1016/j.neuron.2005.09.004
Wu M, Hernandez M, Shen S, Sabo JK, Kelkar D, Wang J, O’Leary R, Phillips GR et al (2012) Differential modulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation. J Neurosci: Off J Soc Neurosci 32(19):6651–6664. doi:10.1523/JNEUROSCI.4876-11.2012
Franco PG, Silvestroff L, Soto EF, Pasquini JM (2008) Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination. Exp Neurol 212(2):458–467
Cai J, Qi Y, Hu X, Tan M, Liu Z, Zhang J, Li Q, Sander M et al (2005) Generation of oligodendrocyte precursor cells from mouse dorsal spinal cord independent of Nkx6 regulation and Shh signaling. Neuron 45(1):41–53
McTigue DM, Horner PJ, Stokes BT, Gage FH (1998) Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 18(14):5354–5365
He F, Qu F, Song F (2012) Aspirin upregulates the expression of neuregulin 1 and survivin after focal cerebral ischemia/reperfusion in rats. Exp Ther Med 3(4):613–616
De Cristobal J, Madrigal JL, Lizasoain I, Lorenzo P, Leza JC, Moro MA (2002) Aspirin inhibits stress-induced increase in plasma glutamate, brain oxidative damage and ATP fall in rats. Neuroreport 13(2):217–221
Modi KK, Sendtner M, Pahan K (2013) Up-regulation of ciliary neurotrophic factor in astrocytes by aspirin: implications for remyelination in multiple sclerosis. J Biol Chem 288(25):18533–18545. doi:10.1074/jbc.M112.447268
Stankoff B, Aigrot MS, Noel F, Wattilliaux A, Zalc B, Lubetzki C (2002) Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J Neurosci 22(21):9221–9227
Chen J, Zuo S, Wang J, Huang J, Zhang X, Liu Y, Zhang Y, Zhao J et al (2014) Aspirin promotes oligodendrocyte precursor cell proliferation and differentiation after white matter lesion. Front Aging Neurosci 6:7. doi:10.3389/fnagi.2014.00007
Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ et al (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23(13):1571–1585. doi:10.1101/gad.1806309
Wang Y, Chen X, Zhu W, Zhang H, Hu S, Cong X (2006) Growth inhibition of mesenchymal stem cells by aspirin: involvement of the WNT/beta-catenin signal pathway. Clin Exp Pharmacol Physiol 33(8):696–701
Rosenberg SS, Chan JR (2009) Modulating myelination: knowing when to say Wnt. Genes Dev 23(13):1487–1493. doi:10.1101/gad.1824009
Niu J, Wang L, Liu S, Li C, Kong J, Shen HY, Xiao L (2012) An efficient and economical culture approach for the enrichment of purified oligodendrocyte progenitor cells. J Neurosci Methods 209(1):241–249. doi:10.1016/j.jneumeth.2012.05.032
Niu J, Mei F, Wang L, Liu S, Tian Y, Mo W, Li H, Lu QR et al (2012) Phosphorylated olig1 localizes to the cytosol of oligodendrocytes and promotes membrane expansion and maturation. Glia 60(9):1427–1436. doi:10.1002/glia.22364
Jahromy FZ, Behnam H, Mansoori K, Rahimi AA, Edalat R, Mobarake JI (2013) The effect of ultrasound on the expression of CNTF gene, a possible cause of ultrasound influence on the rate of injured peripheral nerve regeneration. Australas Phys Eng Sci Med 36(3):323–329. doi:10.1007/s13246-013-0216-y
Beurel E, Grieco SF, Jope RS (2015) Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 148:114–131. doi:10.1016/j.pharmthera.2014.11.016
Zhang Q, Major MB, Takanashi S, Camp ND, Nishiya N, Peters EC, Ginsberg MH, Jian X et al (2007) Small-molecule synergist of the Wnt/beta-catenin signaling pathway. Proc Natl Acad Sci U S A 104(18):7444–7448. doi:10.1073/pnas.0702136104
Magri L, Swiss VA, Jablonska B, Lei L, Pedre X, Walsh M, Zhang W, Gallo V et al (2014) E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation. J Neurosci: Off J Soc Neurosci 34(4):1481–1493. doi:10.1523/JNEUROSCI.2840-13.2014
Dai J, Bercury KK, Macklin WB (2014) Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation. Glia. doi:10.1002/glia.22729
Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Hu T, Taketo MM et al (2009) HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat Neurosci 12(7):829–838. doi:10.1038/nn.2333
He L, Lu QR (2013) Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues. Neurosci Bull 29(2):129–143. doi:10.1007/s12264-013-1318-y
Vane JR, Botting RM (2003) The mechanism of action of aspirin. Thromb Res 110(5–6):255–258. doi:10.1016/s0049-3848(03)00379-7
Tegeder I, Pfeilschifter J, Geisslinger G (2001) Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 15(12):2057–2072
Shaygannejad V, Janghorbani M, Ashtari F, Zakeri H (2012) Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study. Neurol Res 34(9):854–858
Ghosh A, Dhumal VR, Tilak AV, Das N, Singh A, Bondekar AA (2011) Evaluation of nootropic and neuroprotective effects of low dose aspirin in rats. J Pharmacol Pharmacotherapeut 2(1):3–6. doi:10.4103/0976-500X.77079
Moro MA, De Alba J, Cardenas A, De Cristobal J, Leza JC, Lizasoain I, Diaz-Guerra MJ, Bosca L et al (2000) Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices. Neuropharmacology 39(7):1309–1318
Xiao J, Ferner AH, Wong AW, Denham M, Kilpatrick TJ, Murray SS (2012) Extracellular signal-regulated kinase 1/2 signaling promotes oligodendrocyte myelination in vitro. J Neurochem 122(6):1167–1180. doi:10.1111/j.1471-4159.2012.07871.x
Ishii A, Furusho M, Bansal R (2013) Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion. J Neurosci : Off J Soc Neurosci 33(1):175–186. doi:10.1523/JNEUROSCI.4403-12.2013
Shimizu T, Kagawa T, Wada T, Muroyama Y, Takada S, Ikenaka K (2005) Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. Dev Biol 282(2):397–410. doi:10.1016/j.ydbio.2005.03.020
Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, Baranzini SE, Bruce CC, Otero JJ et al (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14(8):1009–1016. doi:10.1038/nn.2855
Thomas T, Nadackal TG, Thomas K (2001) Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation. Neuroreport 12(15):3263–3267
Acknowledgments
This work is supported by the National Natural Science Foundation of China (NSCF 31171046, 31300906) and the Natural Science Foundation Project of Chongqing (CSTC2013jcyjA10100).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Suppl Fig. 1
(GIF 12 kb)
Suppl Fig. 2
(GIF 189 kb)
Rights and permissions
About this article
Cite this article
Huang, N., Chen, D., Wu, X. et al. Aspirin Promotes Oligodendroglial Differentiation Through Inhibition of Wnt Signaling Pathway. Mol Neurobiol 53, 3258–3266 (2016). https://doi.org/10.1007/s12035-015-9241-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-015-9241-z